Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT

Risk Factors for Fluconazole-Resistant Candidemia

(2010) J. Garnacho-Montero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death

(2010) M. A. Slavin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Micafungin Does Not Influence the Concentration of Tacrolimus in Patients After Allogeneic Hematopoietic Stem Cell Transplantation

(2010) N. Fukuoka et al.   TRANSPLANTATION PROCEEDINGS

Diagnosis and therapy of fungal infection in patients with leukemia—new drugs and immunotherapy

(2008) Elias J. Anaissie   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States

(2008) F Aversa   BONE MARROW TRANSPLANTATION

The history and future prospective of haplo-identical stem cell transplantation

(2008) R. Handgretinger et al.   CYTOTHERAPY

Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation

(2008) Yasushi Hiramatsu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

The haploidentical option for high-risk haematological malignancies

(2007) Franco Aversa et al.   BLOOD CELLS MOLECULES AND DISEASES